Microsoft Excel remains a cornerstone for data analysts, offering a wide array of functions to streamline workflows and enhance data accuracy. In this deep dive, Mo Chen highlights ten essential Excel ...

The start-up Function will send practically anyone to a lab for extensive medical testing, no physical required. Is that a good thing? By Kristen V. Brown As Kimberly Crisp approached middle age, ...

Function Health, a startup that offers lab testing and body scans for early disease detection, scored nearly $300 million in series B funding, boosting its valuation to $2.5 billion. Redpoint Ventures ...

Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics. His stories explore how tech is changing the ...

ABSTRACT: The EXO70 gene is a very important component of the exocytosis complex, involving a series of biological processes including plant cell division and immune regulation. The Arabidopsis ...

For decades, neuroscientists have debated whether synaptic vesicles “kiss-and-run” or do an irreversible “full collapse” when releasing neurotransmitters. Now, a team in China has frozen that moment ...

How secretion is regulated during cell division and how membrane trafficking factors cooperate with the cytoskeleton during cell division remain poorly understood. In this work the authors find ...

Function Health said it acquired full-body MRI scanning company Ezra. Function offers a $499 annual subscription where members complete more than 160 blood tests and track their results over time.

Function Health, a preventive health and longevity startup, acquired Ezra to integrate Function’s lab testing capabilities with the company’s artificial-intelligence-powered full-body scans, combining ...

Lysosomes are heterogeneous, acidic organelles whose proper functionality is critically dependent on maintaining the integrity of their membranes and the acidity within their lumen. When subjected to ...

The fight against cancer often begins with uncovering hidden players, and this study reveals one such key player: an unexpected class of abbreviated N-glycans. These molecules, upregulated in cancer ...